# Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

> **NCT05292027** · NA · COMPLETED · sponsor: **Sichuan Cancer Hospital and Research Institute** · enrollment: 84 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **RADIATION:** low-dose radiotherapy

## Key facts

- **NCT ID:** NCT05292027
- **Lead sponsor:** Sichuan Cancer Hospital and Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-26
- **Primary completion:** 2022-11-18
- **Final completion:** 2024-12-12
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2024-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05292027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05292027, "Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05292027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*